GlassScriptPhysician profile
Bradley Champagne
NPI 1154357085
$7,878.96
in general payments reported to CMS, 2019-2025
13 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,303 · 2020: $125 · 2021: $48.01 · 2022: $264 · 2023: $1,234 · 2024: $195 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,862 · Travel and Lodging: $243 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,861.95 |
| Travel and Lodging | $242.84 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $4,878.22 | 2019 | |
| Intuitive Surgical, INC. | $956.74 | 2023 | Da Vinci Surgical System |
| Medtronic, INC. | $538.07 | 2023-2025 | Signia, Ligasure, Eea |
| Innovation Technologies INC | $380.45 | 2025 | Irrisept |
| Conmed Corporation | $373.62 | 2019-2022 | |
| Dilon Technologies, INC. | $158.91 | 2025 | Hemoblast Bellows |
| Ethicon US, LLC | $149.81 | 2019-2022 | |
| Prescient Surgical | $133.76 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $121.34 | 2019 | |
| Guard Medical INC. | $90.84 | 2023 | Npseal Large, Npseal Medium, Npseal (5) |
| Medtronic USA, INC. | $59.67 | 2019 | |
| Merck Sharp & Dohme LLC | $23.41 | 2019 | |
| Axonics, INC. | $14.12 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Champagne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.